학술논문
Sarcopènia en pacients amb obesitat severa intervinguts de cirurgia bariàtrica
Document Type
Dissertation/Thesis
Author
Source
TDX (Tesis Doctorals en Xarxa)
Subject
616.3
Language
Catalan; Valencian
Abstract
La obesidad es una enfermedad muy prevalente mundialmente y supone un gran gasto para el sistema sanitario. Cada vez se tiende más a alcanzar los valores extremos de esta enfermedad. Hasta ahora el método más efectivo para conseguir una rápida pérdida de peso era la cirugía bariátrica (CB), que induce una pérdida de peso significativa en pacientes con obesidad severa. Sin embargo, aparte de reducir significativamente la grasa corporal, también puede perderse masa libre de grasa (MLG). La sarcopenia y, más en concreto, la obesidad sarcopénica han creado gran interés para investigar la prevalencia, la fisiopatología y tratamientos que se pueden utilizar para reducirla, no sólo en edades avanzadas sino también en pacientes jóvenes (<60 años). Las principales conclusiones de este estudio son: existe una pérdida precoz de MLG durante los primeros meses post CB, así como una reducción drástica del metabolismo basal. Suplementar con complementos específicos evita perder MLG.
Obesity is a prevalent disease worldwide and is a considerable expense for the healthcare system. More and more, we tend to reach the extreme values of this disease. Until now, the most effective method to achieve rapid weight loss was bariatric surgery (BS), which induces significant weight loss in severely obese patients. However, you can also lose fat-free mass (FFM) apart from significantly reducing body fat. Sarcopenia and, more specifically, sarcopenic obesity has created great interest in investigating the prevalence, pathophysiology and treatments that can be used to reduce it, not only in advanced ages but also in young patients (<60 years). The main conclusions of this study are: there is an early loss of FFM during the first-month post-BS, as well as a drastic reduction in basal metabolism. Supplementing with specific supplements prevents losing FFM.
Cures Integrals i Serveis de Salut
Obesity is a prevalent disease worldwide and is a considerable expense for the healthcare system. More and more, we tend to reach the extreme values of this disease. Until now, the most effective method to achieve rapid weight loss was bariatric surgery (BS), which induces significant weight loss in severely obese patients. However, you can also lose fat-free mass (FFM) apart from significantly reducing body fat. Sarcopenia and, more specifically, sarcopenic obesity has created great interest in investigating the prevalence, pathophysiology and treatments that can be used to reduce it, not only in advanced ages but also in young patients (<60 years). The main conclusions of this study are: there is an early loss of FFM during the first-month post-BS, as well as a drastic reduction in basal metabolism. Supplementing with specific supplements prevents losing FFM.
Cures Integrals i Serveis de Salut